50 results
Page 2 of 3
424B3
EX-99.2
7me0uslk
25 Feb 22
Prospectus supplement
8:39am
8-K
EX-99.2
d3fkmqj eyr2lkho8yf
25 Feb 22
Regulation FD Disclosure
8:38am
424B3
vkhmhfavks5n m0
12 Nov 21
Prospectus supplement
8:41am
8-K
EX-99.1
ua3g10nykatilrx
13 Aug 21
POINT Biopharma Reports Second Quarter 2021 Financial Results and Provides Business Update
7:00am
424B3
4m3fh4 8f6ma25ucg
5 Aug 21
Prospectus supplement
4:26pm
424B3
2ys vnpfo
9 Jun 21
Prospectus supplement
4:42pm
8-K
EX-99.1
7siztx
4 Jun 21
POINT Biopharma Announces First Patients
4:22pm
425
EX-99.1
qmyxxcg8
4 Jun 21
Business combination disclosure
4:20pm
CORRESP
ibnplo
25 May 21
Correspondence with SEC
12:00am
S-4/A
EX-10.16
vqdg yp5cj5
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
4vrnfj3v949j7jrv2v1
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4
6epiahu
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.16
2mo8ei
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.17
86bj9
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
8-K/A
EX-2.1
hie7z2mrwsqjesjnzhha
18 Mar 21
Financial Statements and Exhibits
9:08am